Abbott Laboratories vs. Silence Therapeutics Plc American Depository Share
ABT
Abbott Laboratories
$114.43 +1.55%
VS SLNSilence Therapeutics Plc American Depository Share
$13.61 -3.48%
Abbott Laboratories (ABT) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| ABT | SLN | |
|---|---|---|
| Market Cap | $194.98 billion | $845.92 million |
| Revenue (TTM) | $46.59 billion | $615,000 |
| Net Income (TTM) | $5.42 billion | $-59,953,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | SLN | |
|---|---|---|
| P/E Ratio | 37.03 | — |
| Price / Book | 3.77 | 21.99 |
| Price / Sales | 4.19 | 1375.47 |
ABT leads on 2 of 2 valuation factors.
Profitability
| ABT | SLN | |
|---|---|---|
| Net Margin | 11.65% | -9748.46% |
| Return on Equity | 10.48% | -155.84% |
ABT leads on 2 of 2 profitability factors.
Dividend
| ABT | SLN | |
|---|---|---|
| Dividend Yield | 2.20% | — |
| Payout Ratio | 81.55 | — |
ABT and SLN split the dividend factors evenly.
Risk & Sentiment
| ABT | SLN | |
|---|---|---|
| Short Interest | 0.57% | 0.00% |
SLN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, SLN overview, SLN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.